Who owns Eiger Biopharmaceuticals?
- Ticker: EIGR
- CUSIP Number: 28249u105
Tip: Access positions for across all investors
Analyze quarterly positions in Eiger Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Eiger Biopharmaceuticals stock
Who bought or sold Eiger Biopharmaceuticals this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Ameriprise Financial | 8.6M | $2.6M | 0% | Sep 2023 |
|
Propel Bio Management | 4.4M | $986k | 100% | Dec 2023 |
|
683 Capital Management | 2.1M | $472k | -21% | Dec 2023 |
|
Vanguard Group | 1.8M | $409k | -7% | Dec 2023 |
|
BlackRock | 886k | $270k | -5% | Sep 2023 |
|
UBS O'Connor | 394k | $120k | 0% | Sep 2023 |
|
Rbf Capital | 391k | $119k | 0% | Sep 2023 |
|
Geode Capital Management | 380k | $116k | 0% | Sep 2023 |
|
Acadian Asset Management | 238k | $71k | 15% | Sep 2023 |
|
State Street Corporation | 147k | $45k | 0% | Sep 2023 |
|
Northern Trust | 112k | $34k | -15% | Sep 2023 |
|
Bridgeway Capital Management | 107k | $33k | -48% | Sep 2023 |
|
Millennium Management | 81k | $18k | -70% | Dec 2023 |
|
Sequoia Financial Advisors | 63k | $14k | 0% | Dec 2023 |
|
Verition Fund Management | 63k | $19k | -58% | Sep 2023 |
|
Two Sigma Securities | 57k | $13k | 60% | Dec 2023 |
|
Bank of America Corporation | 48k | $11k | -4% | Dec 2023 |
|
Tocqueville Asset Management | 37k | $8.4k | -27% | Dec 2023 |
|
Charles Schwab Investment Management | 33k | $7.5k | 0% | Dec 2023 |
|
Dfpg Investments | 32k | $8.0k | 0% | Dec 2023 |
|
Townsquare Capital | 32k | $7.3k | 0% | Dec 2023 |
|
Jane Street | 30k | $6.6k | 100% | Dec 2023 |
|
Morgan Stanley | 30k | $9.0k | -51% | Sep 2023 |
|
Hrt Financial | 29k | $6.0k | 100% | Dec 2023 |
|
Susquehanna International | 22k | $6.6k | -48% | Sep 2023 |
|
Bank of New York Mellon | 21k | $4.6k | 0% | Dec 2023 |
|
Tower Research Capital | 17k | $5.0k | 4% | Sep 2023 |
|
XTX Topco | 16k | $4.8k | -72% | Sep 2023 |
|
Engineers Gate Manager | 15k | $4.4k | 8% | Sep 2023 |
|
Citadel Advisors | 14k | $3.2k | 100% | Dec 2023 |
|
Simplex Trading | 13k | $2.0k | 7% | Dec 2023 |
|
UBS Group | 11k | $2.2k | 19277% | Dec 2023 |
|
Advisor Group Holdings | 7.8k | $1.7k | -65% | Dec 2023 |
|
Qube Research & Technologies | 6.1k | $1.9k | -90% | Sep 2023 |
|
Citigroup | 2.9k | $535.219200 | -21% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 2.9k | $651.948000 | -1% | Dec 2023 |
|
Rhumbline Advisers | 2.3k | $522.000000 | 0% | Dec 2023 |
|
Royal Bank of Canada | 1.4k | $0 | 45% | Dec 2023 |
|
National Bank Of Canada /fi/ | 1.3k | $301.056000 | 0% | Dec 2023 |
|
Cutler | 1.0k | $0 | 0% | Dec 2023 |
|
Sound Income Strategies | 400.00 | $90.000000 | 0% | Dec 2023 |
|
Wells Fargo & Company | 307.00 | $69.351300 | -98% | Dec 2023 |
|
Perkins Coie Trust | 178.00 | $38.999800 | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 166.00 | $37.001400 | -98% | Dec 2023 |
|
Who sold out of Eiger Biopharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Simplify Asset Management | Sep 2023 | 2.7M | $824k |
GSA Capital Partners | Sep 2023 | 356k | $109k |
Y-Intercept | Jun 2023 | 161k | $114k |
DRW Holdings | Sep 2023 | 120k | $37k |
Renaissance Technologies | Jun 2023 | 72k | $50k |
Sigma Planning | Sep 2023 | 42k | $13k |
Ergoteles | Jun 2023 | 41k | $29k |
Old Mission Capital | Jun 2023 | 27k | $19k |
Two Sigma Investments | Sep 2023 | 18k | $5.5k |
FMR | Jun 2023 | 1.6k | $1.1k |
China Universal Asset Management | Sep 2023 | 1.1k | $0 |
Toth Financial Advisory Corporation | Sep 2023 | 335.00 | $103.012500 |